Research Article: Transarterial Chemoembolization Plus Lenvatinib and PD- Inhibitors for Hepatocellular Carcinoma with Main Trunk Portal Vein Tumor Thrombus: A Multicenter Retrospective Study
Introduction:
Hepatocellular carcinoma (HCC) is a major cause of cancer-associated mortality worldwide, with a poor prognosis. A dismal prognostic factor is portal vein tumor thrombus (PVTT), detected in approximately –% of HCC patients at diagnosis and portends a median survival rate of .–. months without treatment.
Read more